Compare Bundamedik Tbk (BMHS) vs Prodia Diagnostic Line Tbk (PRDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Bundamedik Tbk trades at Rp188 (market cap 1.63T, 725.9K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Bundamedik Tbk is far larger — about 3.5× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 725.9K). Which is the better fit depends on your goals.
| BMHS | PRDL | |
|---|---|---|
Market Cap | 1.63T | 470.58B |
Volume | 725.9K | 28.43M |
Lot | 7.26K | 284.34K |
Turnover | 135.94M | 7.8B |
Average Price | 187.26 | 274.19 |
Value | 135.94M | 7.8B |
Indicative Equilibrium Price | 188 | 270 |
Indicative Equilibrium Volume | 1 | 2.1K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Prodia Diagnostic Line Tbk
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →
